Sign up to save your podcasts
Or
Share Updates and Evolving Care Considerations in the Mitigation of Hyperkalemia in Patients with End-Stage Renal Disease on Dialysis - Podcast #2
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Updates and Evolving Care Considerations in the Mitigation of Hyperkalemia in Patients with End-Stage Renal Disease on Dialysis - Podcast #2
In this next episode of the series, experts George L. Bakris, MD and Biff F. Palmer, MD take another stab at the health implications of HK in patients with ESRD and the available strategies for optimizing management. Listen closely as they discuss the challenges in HK identification, the key causes of HK, the importance of appropriate monitoring, & more!
For additional information and to claim credit visit,
https://integrityce.com/hkpodcast2
View the figures referenced during this podcast episode here:
https://integrityce.com/wp-content/uploads/2021/12/i785_podcast-2-figures-2.pdf
Integrity Continuing Education designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Integrity Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Supported by an educational grant from AstraZeneca Pharmaceuticals LP.
Listen to the first episode of this podcast series at,
https://integrityce.com/courses/updates-evolving-care-considerations-in-the-mitigation-of-hyperkalemia-in-patients-with-end-stage-renal-disease-on-dialysis/
View all episodes
By Integrity CEIn this next episode of the series, experts George L. Bakris, MD and Biff F. Palmer, MD take another stab at the health implications of HK in patients with ESRD and the available strategies for optimizing management. Listen closely as they discuss the challenges in HK identification, the key causes of HK, the importance of appropriate monitoring, & more!
For additional information and to claim credit visit,
https://integrityce.com/hkpodcast2
View the figures referenced during this podcast episode here:
https://integrityce.com/wp-content/uploads/2021/12/i785_podcast-2-figures-2.pdf
Integrity Continuing Education designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Integrity Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Supported by an educational grant from AstraZeneca Pharmaceuticals LP.
Listen to the first episode of this podcast series at,
https://integrityce.com/courses/updates-evolving-care-considerations-in-the-mitigation-of-hyperkalemia-in-patients-with-end-stage-renal-disease-on-dialysis/